Baidu
map

重症患者凝血功能障碍标准化评估中国专家共识

2022-02-09 解放军联勤保障部队第908医院重症医学科 解放军医学杂志

40%以上的重症患者会发生凝血功能障碍,合并凝血功能障碍的重症患者出血不良事件、输血量及病死率可升高4倍以上。早期识别凝血功能障碍并准确评估凝血功能,是尽快纠正凝血功能障碍的前提及保障,但目前国内外尚

中文标题:

重症患者凝血功能障碍标准化评估中国专家共识

发布日期:

2022-02-09

简要介绍:

40%以上的重症患者会发生凝血功能障碍,合并凝血功能障碍的重症患者出血不良事件、输血量及病死率可升高4倍以上。早期识别凝血功能障碍并准确评估凝血功能,是尽快纠正凝血功能障碍的前提及保障,但目前国内外尚缺乏如何快速、准确评估重症患者凝血功能障碍的标准。为此,全军重症医学专业委员会联合中国医药教育协会血栓与止血危重病专业委员会组织临床专家共同制定了《重症患者凝血功能障碍标准化评估中国专家共识》。本共识包括重症患者凝血功能障碍的有关概念、评估方法及诊断标准3个部分,共12条推荐意见,以期为临床工作提供相应指导。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=重症患者凝血功能障碍标准化评估中国专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1a2761c0023e86be, title=重症患者凝血功能障碍标准化评估中国专家共识, enTitle=, guiderFrom=解放军医学杂志, authorId=0, author=, summary=40%以上的重症患者会发生凝血功能障碍,合并凝血功能障碍的重症患者出血不良事件、输血量及病死率可升高4倍以上。早期识别凝血功能障碍并准确评估凝血功能,是尽快纠正凝血功能障碍的前提及保障,但目前国内外尚, cover=https://img.medsci.cn/2022312/1647086381166_5579292.jpg, journalId=0, articlesId=null, associationId=2508, associationName=解放军联勤保障部队第908医院重症医学科, associationIntro=解放军联勤保障部队第908医院重症医学科, copyright=0, guiderPublishedTime=Wed Feb 09 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">40%以上的重症患者会发生凝血功能障碍,合并凝血功能障碍的重症患者出血不良事件、输血量及病死率可升高4倍以上。早期识别凝血功能障碍并准确评估凝血功能,是尽快纠正凝血功能障碍的前提及保障,但目前国内外尚缺乏如何快速、准确评估重症患者凝血功能障碍的标准。为此,全军重症医学专业委员会联合中国医药教育协会血栓与止血危重病专业委员会组织临床专家共同制定了《重症患者凝血功能障碍标准化评估中国专家共识》。本共识包括重症患者凝血功能障碍的有关概念、评估方法及诊断标准3个部分,共12条推荐意见,以期为临床工作提供相应指导。&nbsp;</span></p>, tagList=[TagDto(tagId=80073, tagName=凝血功能障碍), TagDto(tagId=124242, tagName=血栓|止血)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=29227, appHits=335, showAppHits=0, pcHits=985, showPcHits=28891, likes=0, shares=66, comments=5, approvalStatus=1, publishedTime=Sun Mar 13 15:26:00 CST 2022, publishedTimeString=2022-02-09, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Mar 12 20:02:32 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Fri Jan 05 13:25:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=重症患者凝血功能障碍标准化评估中国专家共识.pdf)])
重症患者凝血功能障碍标准化评估中国专家共识.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1210974, encodeId=362c12109e452, content=我想知道咋处理!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Wed Apr 13 22:05:33 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206323, encodeId=44c31206323e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 27 11:57:48 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206246, encodeId=575912062463c, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Mar 26 22:40:05 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202428, encodeId=c4f512024285b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTuPLbu8kEYibb1bgxiauMtAjKUUIzSvzSOo2micqyL9MNsPqc7tS6zBQEVqGV9fHiaiaia8cpqRgFEy2A/132, createdBy=56192254050, createdName=岁月的泡沫, createdTime=Mon Mar 14 11:32:01 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202286, encodeId=597b120228659, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37036543416, createdName=ms4000001557041203, createdTime=Sun Mar 13 18:38:07 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-04-13 最后一支肾上腺素

    我想知道咋处理!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1210974, encodeId=362c12109e452, content=我想知道咋处理!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Wed Apr 13 22:05:33 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206323, encodeId=44c31206323e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 27 11:57:48 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206246, encodeId=575912062463c, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Mar 26 22:40:05 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202428, encodeId=c4f512024285b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTuPLbu8kEYibb1bgxiauMtAjKUUIzSvzSOo2micqyL9MNsPqc7tS6zBQEVqGV9fHiaiaia8cpqRgFEy2A/132, createdBy=56192254050, createdName=岁月的泡沫, createdTime=Mon Mar 14 11:32:01 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202286, encodeId=597b120228659, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37036543416, createdName=ms4000001557041203, createdTime=Sun Mar 13 18:38:07 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-03-27 120c570cm03暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1210974, encodeId=362c12109e452, content=我想知道咋处理!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Wed Apr 13 22:05:33 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206323, encodeId=44c31206323e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 27 11:57:48 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206246, encodeId=575912062463c, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Mar 26 22:40:05 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202428, encodeId=c4f512024285b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTuPLbu8kEYibb1bgxiauMtAjKUUIzSvzSOo2micqyL9MNsPqc7tS6zBQEVqGV9fHiaiaia8cpqRgFEy2A/132, createdBy=56192254050, createdName=岁月的泡沫, createdTime=Mon Mar 14 11:32:01 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202286, encodeId=597b120228659, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37036543416, createdName=ms4000001557041203, createdTime=Sun Mar 13 18:38:07 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-03-26 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1210974, encodeId=362c12109e452, content=我想知道咋处理!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Wed Apr 13 22:05:33 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206323, encodeId=44c31206323e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 27 11:57:48 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206246, encodeId=575912062463c, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Mar 26 22:40:05 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202428, encodeId=c4f512024285b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTuPLbu8kEYibb1bgxiauMtAjKUUIzSvzSOo2micqyL9MNsPqc7tS6zBQEVqGV9fHiaiaia8cpqRgFEy2A/132, createdBy=56192254050, createdName=岁月的泡沫, createdTime=Mon Mar 14 11:32:01 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202286, encodeId=597b120228659, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37036543416, createdName=ms4000001557041203, createdTime=Sun Mar 13 18:38:07 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-03-14 岁月的泡沫

    实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1210974, encodeId=362c12109e452, content=我想知道咋处理!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=509f5553241, createdName=最后一支肾上腺素, createdTime=Wed Apr 13 22:05:33 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206323, encodeId=44c31206323e2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 27 11:57:48 CST 2022, time=2022-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206246, encodeId=575912062463c, content=学习了,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Mar 26 22:40:05 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202428, encodeId=c4f512024285b, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqTuPLbu8kEYibb1bgxiauMtAjKUUIzSvzSOo2micqyL9MNsPqc7tS6zBQEVqGV9fHiaiaia8cpqRgFEy2A/132, createdBy=56192254050, createdName=岁月的泡沫, createdTime=Mon Mar 14 11:32:01 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202286, encodeId=597b120228659, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37036543416, createdName=ms4000001557041203, createdTime=Sun Mar 13 18:38:07 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-03-13 ms4000001557041203

    学习

    0

Baidu
map
Baidu
map
Baidu
map